ロード中...
Use of pulmonary arterial hypertension–approved therapy in the treatment of non–group 1 pulmonary hypertension at US referral centers
Abstract. Pulmonary hypertension (PH) is a frequent complication of left heart disease and parenchymal lung disease, and it portends increased mortality. A growing number of medications are approved for the treatment of World Health Organization (WHO) group 1 pulmonary arterial hypertension (PAH). H...
保存先:
| 出版年: | Pulm Circ |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
University of Chicago Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4449248/ https://ncbi.nlm.nih.gov/pubmed/26064462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/681264 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|